An otherwise healthy 42-year-old woman is evaluated during a telemedicine consultation to … — USMLE Step 3

An otherwise healthy 42-year-old woman is evaluated during a telemedicine consultation to discuss recent blood work results. She recently underwent a comprehensive metabolic panel for life insurance underwriting. The patient reports feeling entirely well and denies bone pain, abdominal discomfort, frequent urination, or mood changes. Her past medical history is unremarkable, and she takes no daily medications or supplements. Initial laboratory results show a serum calcium level of $11.3 \text{ mg/dL}$ (reference range: $8.4-10.2 \text{ mg/dL}$ ), serum albumin of $4.0 \text{ g/dL}$ , and serum intact parathyroid hormone (PTH) of $58 \text{ pg/mL}$ (reference range: $15-65 \text{ pg/mL}$ ). Serum creatinine is $0.8 \text{ mg/dL}$ , and 25-hydroxyvitamin D is $34 \text{ ng/mL}$ (reference range: $20-50 \text{ ng/mL}$ ). Which of the following is the most appropriate next step in laboratory evaluation?

Measurement of 24-hour urinary calcium excretionAnswer
B
Measurement of serum parathyroid hormone-related peptide (PTHrP)
C
Measurement of serum 1,25-dihydroxyvitamin D
D
Technetium-99m sestamibi parathyroid scintigraphy
E
Measurement of serum protein electrophoresis

Answer

Measurement of 24-hour urinary calcium excretion

The patient presents with hypercalcemia (

11.3 \text{ mg/dL}

) and an intact PTH level (

58 \text{ pg/mL}

) that is in the upper half of the normal reference range. In a patient with hypercalcemia, normal physiological feedback should cause near-complete suppression of PTH. Therefore, this 'normal' PTH level is inappropriately unsuppressed, establishing a diagnosis of PTH-dependent hypercalcemia. The differential diagnosis for PTH-dependent hypercalcemia is narrowed down to primary hyperparathyroidism and familial hypocalciuric hypercalcemia (FHH). FHH is an autosomal dominant disorder characterized by a defective calcium-sensing receptor in the parathyroid glands and kidneys, leading to hypercalcemia, inappropriately normal PTH, and extremely low urinary calcium excretion. Because FHH is a benign condition that does not require surgical intervention, it must be ruled out before diagnosing primary hyperparathyroidism. The most appropriate next step in laboratory evaluation is the measurement of 24-hour urinary calcium excretion (often with concurrent creatinine to calculate a clearance ratio).

Step-by-Step Solution

Analyze the serum calcium and PTH levels.

Calcium is elevated at

11.3 \text{ mg/dL}

and PTH is

58 \text{ pg/mL}

In the setting of hypercalcemia, a normal PTH level (

58 \text{ pg/mL}

) is inappropriately high. The parathyroid glands should be completely suppressed by the high calcium. This indicates PTH-dependent hypercalcemia.

Formulate a differential diagnosis for PTH-dependent hypercalcemia.

The two primary etiologies are primary hyperparathyroidism and familial hypocalciuric hypercalcemia (FHH).

Both conditions present with elevated calcium and normal-to-elevated PTH levels, making them clinically indistinguishable on initial labs.

Determine the laboratory test required to differentiate the conditions.

A 24-hour urine collection for calcium and creatinine is required to calculate the calcium-creatinine clearance ratio.

FHH is caused by a mutated calcium-sensing receptor leading to increased renal calcium reabsorption (urine calcium

< 100 \text{ mg/day}

or clearance ratio

< 0.01

), whereas primary hyperparathyroidism typically has higher urine calcium excretion. Differentiating them is critical because FHH is benign and does not require parathyroidectomy.

Key Concept

The evaluation of PTH-dependent hypercalcemia (elevated calcium with inappropriately normal or elevated PTH) requires measurement of 24-hour urinary calcium excretion to differentiate primary hyperparathyroidism from familial hypocalciuric hypercalcemia.

Question

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Topics

More questions from this topic